Carbohydrate Bioengineering is recognized today as a pillar of biotechnology and biological engineering. It offers major assets to face many of our modern life challenges, promote innovative medical treatments or elaborate functional food, biopharmaceuticals, active cosmetics, biomaterials, to name just a few. In particular, researches in glycobiology, multi-omic data integration, structure/function relationships, enzyme engineering, biocatalysis, biophysics and process development are key drivers to expand opportunities in this field. More than ever, knowledge between carbohydrate players must be shared and crossing and bridging the disciplinary boundaries are essential to open new horizons of developments for the benefit of all. This will be the objective of CBM14.
In keeping with the previous CBMs, the conference will bring together glycoscientists coming from all over the world to share their latest findings and most exciting achievements in a friendly and warm atmosphere. Experts from research institutions or private companies will open each session, which will be followed by presentations selected from submitted abstracts.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.